Feed Preview

Fast Growing

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome diagram by Yasuhito Nakatomi et al.
Yasuhito Nakatomi et al.

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Top 20 most recent papers
BMJ Open

Correction: unidentified chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics

BMJ OpenNovember 10, 2019
The Cochrane Database of Systematic Reviews

Exercise therapy for chronic fatigue syndrome

The Cochrane Database of Systematic ReviewsOctober 2, 2019
Lillebeth LarunJonathan R Price
70
2
6
1
Medicine

Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions

MedicineSeptember 1, 2019
Adrian Hugh HealdAndreas Walther
26
Medicine

Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis

MedicineOctober 1, 2019
Maximillian J NelsonKade Davison
77
9
Internal Medicine

Successful Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome with Chronic Febricula Using the Traditional Japanese Medicine Shosaikoto

Internal MedicineSeptember 18, 2019
Takehiro NumataTadashi Ishii
9
3
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation

Psychometric properties of the PROMIS® Fatigue Short Form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and RehabilitationSeptember 10, 2019
Manshu YangJin-Mann Sally Lin
5
3
BMJ Open

Characterising the gut microbiome in veterans with Gulf War Illness: a protocol for a longitudinal, prospective cohort study

BMJ OpenAugust 19, 2019
Julie A KeatingNasia Safdar
4
12
Sleep & Breathing = Schlaf & Atmung

Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States

Sleep & Breathing = Schlaf & AtmungSeptember 13, 2019
Chitra LalCharlie Strange
BMC Public Health

Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain

BMC Public HealthJune 28, 2019
Jesús Castro-MarreroJosé M Alegre
46
1
17
Pharmacological Research : the Official Journal of the Italian Pharmacological Society

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

Pharmacological Research : the Official Journal of the Italian Pharmacological SocietySeptember 8, 2019
Gerwyn MorrisMichael Berk
7
5
Chronic Diseases and Translational Medicine

Symptom frequency and development of a generic functional disorder symptom scale suitable for use in studies of patients with irritable bowel syndrome, fibromyalgia syndrome or chronic fatigue syndrome

Chronic Diseases and Translational MedicineJune 1, 2019
Michael E HylandAnthony F Davies
1
1
8
Medical Humanities

Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox

Medical HumanitiesJune 18, 2019
Michael Sharpe, Monica Greco
171
5
9
1
Journal of Health Psychology

Monitoring treatment harm in myalgic encephalomyelitis/chronic fatigue syndrome: A freedom-of-information study of National Health Service specialist centres in England

Journal of Health PsychologyJune 24, 2019
Graham McPheeBrian M Hughes
211
6
6
Neuroscience and Biobehavioral Reviews

Inflammatory proteins are altered in chronic fatigue syndrome-A systematic review and meta-analysis

Neuroscience and Biobehavioral ReviewsAugust 26, 2019
Rebecca StrawbridgeAnthony James Cleare
20
BMC Neurology

A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)

BMC NeurologyAugust 24, 2019
Matthew CorbittSonya M Marshall-Gradisnik
44
5
10
Frontiers in Pediatrics

Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study

Frontiers in PediatricsMay 24, 2019
Melanie PerezLubov Nathanson
60
6
19
Frontiers in Immunology

Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Frontiers in ImmunologyAugust 14, 2019
Jonas BlombergCarl-Gerhard Gottfries
73
11
7
NeuroImage. Clinical

Intra brainstem connectivity is impaired in chronic fatigue syndrome

NeuroImage. ClinicalOctober 19, 2019
Leighton R BarndenSandeep Bhuta
145
14
1
The International Journal of Neuroscience

Is the efficacy of repetitive transcranial magnetic stimulation influenced by baseline severity of fatigue symptom in patients with myalgic encephalomyelitis

The International Journal of NeuroscienceSeptember 5, 2019
De Gang YangWataru Kakuda
1
1
Archives of Disease in Childhood

Illness duration, mood and symptom impact in adolescents with chronic fatigue syndrome/myalgic encephalomyelitis?

Archives of Disease in ChildhoodJune 13, 2019
Francesca K NealeTerry Yvonne Segal
1
2

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2019 Meta ULC. All rights reserved
/feed-previews/chronic-fatigue-syndrome/68dbfb0f-e560-4919-bf8f-e99721cadd22